Gene: HPS6
Official Full Name: HPS6 biogenesis of lysosomal organelles complex 2 subunit 3provided by HGNC
Gene Summary: This intronless gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 5 protein. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 6. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17062 | HPS6 Knockout cell line (HeLa) | Human | HPS6 | 1:3~1:6 | Negative | Online Inquiry |
KO17063 | HPS6 Knockout cell line (HCT 116) | Human | HPS6 | 1:2~1:4 | Negative | Online Inquiry |
KO17064 | HPS6 Knockout cell line (HEK293) | Human | HPS6 | 1:3~1:6 | Negative | Online Inquiry |
KO17065 | HPS6 Knockout cell line (A549) | Human | HPS6 | 1:3~1:4 | Negative | Online Inquiry |
HPS6 Gene Knockout Cell Lines are genetically engineered cellular models that have been specifically designed to lack the expression of the HPS6 gene. This product serves as a pivotal tool for researchers studying the biological implications of HPS6 in various cellular processes and disease states. These cell lines are generated using advanced genome-editing technologies, such as CRISPR-Cas9, which allows for precise modifications in genomic sequences, thereby facilitating the analysis of gene function and regulation.
The key functions of HPS6 Gene Knockout Cell Lines include enabling the examination of the role of HPS6 in autophagy, lysosomal function, and cell signaling pathways. By comparing these knockout lines to their wild-type counterparts, researchers can elucidate the molecular mechanisms underlying HPS6-related cellular dysfunctions and identify potential therapeutic targets. Such investigations are crucial for understanding various neurodegenerative diseases, metabolic disorders, and cancer, where lysosomal integrity and autophagic processes are significantly impacted.
From a scientific perspective, these knockout cell lines provide invaluable models for both basic and applied research. They allow researchers to conduct pathway analyses, drug screening, and gene therapy developments with greater precision. The specific advantage of HPS6 Gene Knockout Cell Lines lies in their reliable performance and reproducibility; researchers can achieve consistent results across different experiments, thus enhancing the credibility of their findings.
In contrast to other gene-editing technologies or alternatives like transient knockdown approaches, HPS6 Gene Knockout Cell Lines offer a stable and permanent solution for investigating gene function, making them an essential asset for laboratories focused on genetic research and therapeutic innovations.
For researchers and clinicians dedicated to advancing the understanding of cellular mechanisms, HPS6 Gene Knockout Cell Lines represent a valuable asset that not only boosts scientific inquiry but also possesses significant potential for clinical applications in future therapeutic developments. Our company is committed to providing high-quality, innovative biological products that empower researchers to push the boundaries of scientific discovery. With our expertise in genetic engineering, we strive to support the research community in translating findings into impactful solutions for human health.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.